(Q36498959)

14 August 2017

1 reference

title

Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression? (English)

1 reference

14 August 2017

1 reference

Scott R Marshall

1

1 reference

14 August 2017

1 June 2006

1 reference

Nature Clinical Practice Oncology

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

6

1 reference

14 August 2017

302-314

1 reference

Mechanisms underlying UV-induced immune suppression

14 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Management of acute graft versus host disease (GvHD).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Mechanisms of action of extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Psoralen ultraviolet A therapy in 2004.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Therapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photopheresis technical aspects

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Photopheresis for renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy in the treatment of severe psoriatic arthropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treatment of severe atopic dermatitis with extracorporeal photopheresis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Steroid-refractory graft-vs.-host disease: past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

The North American experience with photopheresis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy for graft versus host disease in pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Update on extracorporeal photochemotherapy for graft-versus-host disease treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Photopheresis for the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Antigen-Specific Tolerance Induced by Autoimmunization with Photoinactivated Syngeneic Effector Cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Induction of a cell-transferable suppression of alloreactivity by photodamaged lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Modulation of cytokine production by 8-methoxypsoralen and UVA.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Immunopathogenesis and therapy of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

A blast from the past: clearance of apoptotic cells regulates immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Dendritic cell lineage, plasticity and cross-regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Transimmunization, a novel approach for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Apoptosis in leukocytes induced by UVA in the presence of 8-methoxypsoralen, chlorpromazine or 4,6,4'-trimethylangelicin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

The lack of efficacy of 4,6,6'-trimethylangelicin to induce immune suppression in an animal model for photopheresis: a comparison with 8-MOP.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0511

7 January 2021

Identifiers

DOI

10.1038/NCPONC0511

1 reference

14 August 2017

1 reference

PubMed ID

16757968